Business

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMP...

Varma Mutual Pension Insurance Company has reduced its holding in Faron Pharmaceuticals Ltd, crossing a threshold on February 11, 2026. The notification indicates a decrease in holdings, with Varma's voting rights now standing at 2.2%, representing 2,633,674 voting rights. This is a decrease from their previous notification where they held 4.16% of the voting rights. Disclaimer*

articleFaron Pharmaceuticals OyMarch 11, 20263/company/faron-pharmaceuticals-oy/news/faron-pharmaceuticals-ltd-holdings-in-comp
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMP...

About this update from Faron Pharmaceuticals Oy

[{"type":"text","content":"\n\n \n Faron Pharmaceuticals Ltd | Company announcement | March 11, 2026 at 10:00:00 EET\nTR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:Faron Pharmaceuticals Ltd1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuerX2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition or disposal of voting rightsXAn acquisition or disposal of financial instrumentsAn event changing the breakdown of voting rightsOther (please specify) iii: Decrease of holdings3. Details of person subject to the notification obligation ivNameVarma Mutual Pension Insurance CompanyCity and country of registered office (if applicable)Helsinki, Finland4. Full name of shareholder(s) (if different from 3.) vNameCity and country of registered office (if applicable)5. Date on which the threshold was crossed or reached vi:11.2.20266. Date on which issuer notified (DD/MM/YYYY):10.3.20267. Total positions of person(s) subject to the notification obligation% of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer (8.A + 8.B) viiResulting situation on the date on which threshold was crossed or reached2.2%2.2%2,633,674Position of previous notification (ifapplicable)4.16%4.16%8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viiiA: Voting rights attached to sharesClass/type ofsharesISIN code (if possible)Number of voting rights ix% of voting rightsDirect(DTR5.1)Indirect(DTR5.2.1)Direct(DTR5.1)Indirect(DTR5.2.1)FI40001533092,633,6742.2%SUBTOTAL 8. A2,633,6742.2%B 1: Financial Instruments according to DTR5.3.1R (1) (a)Type of financial instrumentExpirationdate xExercise/ Conversion Period xiNumber of voting rights that may be acquired if the instrument isexercised/converted.% of voting rightsSUBTOTAL 8. B 1B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)Type of financial instrumentExpirationdate xExercise/ Conversion P...

More updates from Faron Pharmaceuticals Oy